GlassScriptPhysician profile
Roy A Mages
NPI 1730148289
$2,536.72
in general payments reported to CMS, 2019-2025
16 companies · $287 in 2025
The $287 reported for 2025 was more than what 83% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $304 · 2021: $392 · 2022: $418 · 2023: $305 · 2024: $601 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,193.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $605.16 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $446.24 | 2023-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $442.16 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $297.32 | 2021-2025 | Azstarys |
| Cranial Technologies, INC | $115.45 | 2019-2025 | Doc Band |
| Neos Therapeutics, LP | $115.27 | 2019-2024 | Cotempla Xr-Odt |
| Pfizer INC. | $103.36 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $97.95 | 2024-2025 | |
| Sanofi Pasteur INC. | $83.09 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $72.50 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $48.08 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.30 | 2019-2020 | |
| Genentech USA, INC. | $27.28 | 2019-2020 | |
| Phadia US INC. | $17.58 | 2023 | Immunocap |
| Strongbridge US INC. | $16.56 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.42 | 2025 | Rotateq, Vaxelis, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Mages listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.